药物遗传学与个性化医疗。 - Suppr

Suppr

超能文献

Pharmacogenetics and personalized medicine.

作者信息

Li-Wan-Po A

出版信息

J Clin Pharm Ther. 2012 Dec;37(6):617-9. doi: 10.1111/jcpt.12010. Epub 2012 Sep 27.

DOI:10.1111/jcpt.12010

PMID:23013532

Abstract

摘要

相似文献

Pharmacogenetics and personalized medicine.

J Clin Pharm Ther. 2012 Dec;37(6):617-9. doi: 10.1111/jcpt.12010. Epub 2012 Sep 27.

Drugs, diabetes and pharmacogenomics: the road to personalized therapy.

Pharmacogenomics. 2011 May;12(5):699-701. doi: 10.2217/pgs.11.29.

[Translational approach for pharmacogenomics and personalized medicine].

Yao Xue Xue Bao. 2011 Jan;46(1):1-5.

Personalized medicine for patients with asthma.

J Allergy Clin Immunol. 2010 Feb;125(2):305-6. doi: 10.1016/j.jaci.2009.11.038.

Pharmacogenomics and active surveillance for serious adverse drug reactions in children.

Pharmacogenomics. 2010 Sep;11(9):1269-85. doi: 10.2217/pgs.10.111.

TPMT gene polymorphisms: on the doorstep of personalized medicine.

Indian J Med Res. 2009 May;129(5):478-80.

A piece in the puzzle of personalized medicine.

Clin Pharmacol Ther. 2010 Jan;87(1):19-20. doi: 10.1038/clpt.2009.219.

Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.

Am J Cardiovasc Drugs. 2013 Apr;13(2):79-85. doi: 10.1007/s40256-013-0020-9.

Pharmacogenetics of pharmacoecology: which route to personalized medicine?

Clin Pharmacol Ther. 2009 Apr;85(4):343-8. doi: 10.1038/clpt.2009.17.

[Pharmacogenetic aspects of current pharmacotherapy].

Cas Lek Cesk. 2010;149(10):472-5.

引用本文的文献

Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapy.

Discov Oncol. 2024 Nov 11;15(1):641. doi: 10.1007/s12672-024-01509-9.

Approval gap of pharmacogenomic biomarkers and in vitro companion diagnostics between the United States and Japan.

J Clin Pharm Ther. 2014 Apr;39(2):210-4. doi: 10.1111/jcpt.12129. Epub 2014 Jan 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Pharmacogenetics and personalized medicine.

J Clin Pharm Ther. 2012 Dec;37(6):617-9. doi: 10.1111/jcpt.12010. Epub 2012 Sep 27.

Drugs, diabetes and pharmacogenomics: the road to personalized therapy.

Pharmacogenomics. 2011 May;12(5):699-701. doi: 10.2217/pgs.11.29.

[Translational approach for pharmacogenomics and personalized medicine].

Yao Xue Xue Bao. 2011 Jan;46(1):1-5.

Personalized medicine for patients with asthma.

J Allergy Clin Immunol. 2010 Feb;125(2):305-6. doi: 10.1016/j.jaci.2009.11.038.

Pharmacogenomics and active surveillance for serious adverse drug reactions in children.

Pharmacogenomics. 2010 Sep;11(9):1269-85. doi: 10.2217/pgs.10.111.

TPMT gene polymorphisms: on the doorstep of personalized medicine.

Indian J Med Res. 2009 May;129(5):478-80.

A piece in the puzzle of personalized medicine.

Clin Pharmacol Ther. 2010 Jan;87(1):19-20. doi: 10.1038/clpt.2009.219.

Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.

Am J Cardiovasc Drugs. 2013 Apr;13(2):79-85. doi: 10.1007/s40256-013-0020-9.

Pharmacogenetics of pharmacoecology: which route to personalized medicine?

Clin Pharmacol Ther. 2009 Apr;85(4):343-8. doi: 10.1038/clpt.2009.17.

[Pharmacogenetic aspects of current pharmacotherapy].

Cas Lek Cesk. 2010;149(10):472-5.

引用本文的文献

Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapy.

Discov Oncol. 2024 Nov 11;15(1):641. doi: 10.1007/s12672-024-01509-9.

Approval gap of pharmacogenomic biomarkers and in vitro companion diagnostics between the United States and Japan.

J Clin Pharm Ther. 2014 Apr;39(2):210-4. doi: 10.1111/jcpt.12129. Epub 2014 Jan 10.